Complete Filing Data
TransMedics Group, Inc. reported Net Income Loss of $190.29 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean TransMedics Group, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | $190.3M | $35.5M | -$25.0M | -$36.2M | -$44.2M | -$28.7M | -$33.5M | -$23.8M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $488.0K | -$165.0K | $26.0K | -$73.0K | -$46.0K | -$49.0K | $45.0K | $41.0K |
| Revenues | $605.5M | $441.5M | $241.6M | $93.5M | $30.3M | $25.6M | $23.6M | $13.0M |
| Operating Income Loss | $108.6M | $37.5M | -$28.7M | -$31.4M | -$39.4M | -$26.4M | -$29.6M | -$20.2M |
| Gross Profit | $362.8M | $262.1M | $154.1M | $65.3M | $21.2M | $16.6M | $13.9M | $5.7M |
| Selling General And Administrative Expense | $185.2M | $168.6M | $119.6M | $69.9M | $38.3M | $24.2M | $23.6M | $12.3M |
| Research And Development Expense | $69.1M | $56.0M | $36.1M | $26.8M | $22.3M | $18.8M | $19.9M | $13.7M |
| Other Comprehensive Income Loss Net Of Tax | $488.0K | -$165.0K | $26.0K | -$37.0K | -$93.0K | -$93.0K | $99.0K | $48.0K |
| Operating Expenses | $254.2M | $224.6M | $182.8M | $96.7M | $60.6M | $43.0M | $43.5M | $26.0M |
| Nonoperating Income Expense | -$1.1M | -$1.7M | $2.1M | -$4.7M | -$4.8M | -$2.3M | -$3.9M | -$3.5M |
| Cost Of Revenue | $242.7M | $179.5M | $87.5M | $28.2M | $9.1M | $9.0M | $9.7M | $7.3M |
| Comprehensive Income Net Of Tax | $190.8M | $35.3M | -$25.0M | -$36.3M | -$44.3M | -$28.8M | -$33.4M | -$23.7M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $36.0K | -$47.0K | -$44.0K | $54.0K | $7.0K | |||
| Current Income Tax Expense Benefit | -$1.6M | $66.0K | $36.0K | $32.0K | $40.0K | $41.0K | ||
| Interest Expense | $10.8M | $3.7M | $3.9M | $4.0M | $4.4M | $2.7M | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Other Nonoperating Income Expense | $12.8M | -$1.0M | -$877.0K | $1.7M | $790.0K | -$213.0K | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $107.5M | $35.8M | -$26.7M | -$36.2M | -$44.2M | -$28.7M | ||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$28.7M | -$33.5M | -$23.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $24.3M | $34.9M | $25.7M | $4.2M | $12.2M | $12.2M | -$25.4M | -$1.0M | -$2.6M | -$7.4M | -$11.5M | -$10.6M | -$13.0M | -$10.7M | -$7.9M | -$6.3M | -$5.1M | -$8.5M | -$8.9M | -$9.2M | -$8.3M | -$9.2M | -$6.9M | -$7.6M | -$5.1M | -$6.1M | -$4.9M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $3.0K | $425.0K | $37.0K | $4.0K | -$55.0K | $17.0K | -$42.0K | -$2.0K | $7.0K | -$41.0K | -$30.0K | -$24.0K | $3.0K | -$27.0K | -$2.0K | $16.0K | -$42.0K | $16.0K | $56.0K | -$21.0K | $34.0K | $12.0K | -$2.0K | -$6.0K | |||
| Revenues | $143.8M | $157.4M | $143.5M | $108.8M | $114.3M | $96.9M | $66.4M | $52.5M | $41.6M | $25.7M | $20.5M | $15.9M | $5.4M | $8.2M | $7.1M | $7.6M | $7.1M | $3.4M | $7.5M | $6.1M | $7.2M | $5.7M | $4.7M | $3.5M | $4.0M | $2.9M | $2.5M |
| Operating Income Loss | $23.3M | $36.6M | $27.4M | $3.9M | $12.5M | $12.4M | -$28.3M | -$906.0K | -$2.1M | -$5.5M | -$9.7M | -$9.4M | -$11.7M | -$9.9M | -$6.5M | -$5.9M | -$4.6M | -$7.9M | -$8.0M | -$8.7M | -$7.2M | -$7.7M | -$6.0M | -$6.4M | -$3.9M | -$5.2M | -$4.8M |
| Gross Profit | $84.6M | $96.6M | $88.2M | $60.8M | $69.3M | $60.0M | $40.7M | $36.7M | $28.8M | $18.1M | $14.4M | $12.1M | $3.8M | $5.6M | $4.8M | $4.8M | $5.0M | $1.9M | $4.9M | $3.7M | $4.2M | $3.3M | $2.6M | $1.5M | $2.1M | $1.2M | $924.0K |
| Selling General And Administrative Expense | $46.0M | $44.1M | $43.6M | $42.7M | $42.9M | $36.2M | $30.7M | $29.4M | $25.0M | $16.9M | $17.4M | $13.9M | $10.3M | $9.2M | $6.8M | $5.5M | $5.9M | $6.7M | $6.5M | $6.3M | $4.7M | $2.8M | $2.9M | $2.2M | |||
| Research And Development Expense | $15.3M | $15.9M | $17.2M | $14.3M | $13.9M | $11.4M | $11.1M | $8.3M | $5.9M | $6.8M | $6.7M | $7.5M | $5.2M | $6.3M | $4.5M | $4.2M | $3.9M | $6.2M | $4.9M | $4.8M | $3.9M | $3.3M | $3.4M | $3.5M | |||
| Other Comprehensive Income Loss Net Of Tax | $3.0K | $425.0K | $37.0K | $4.0K | -$55.0K | $17.0K | -$42.0K | -$2.0K | $7.0K | $59.0K | -$21.0K | -$97.0K | $3.0K | -$45.0K | $6.0K | -$52.0K | -$191.0K | $229.0K | $78.0K | $9.0K | $34.0K | $12.0K | $1.0K | -$2.0K | |||
| Operating Expenses | $61.3M | $60.0M | $60.8M | $56.9M | $56.8M | $47.5M | $69.0M | $37.6M | $30.9M | $23.7M | $24.1M | $21.5M | $15.5M | $15.5M | $11.3M | $9.6M | $9.8M | $12.9M | $11.5M | $11.0M | $8.5M | $6.1M | $6.3M | $5.7M | |||
| Nonoperating Income Expense | -$269.0K | -$385.0K | -$767.0K | $322.0K | -$355.0K | -$28.0K | $1.4M | -$74.0K | -$536.0K | -$1.9M | -$1.8M | -$1.2M | -$1.2M | -$794.0K | -$1.4M | -$472.0K | -$630.0K | -$825.0K | -$1.0M | -$1.5M | -$923.0K | -$1.2M | -$951.0K | -$113.0K | |||
| Cost Of Revenue | $59.2M | $60.8M | $55.3M | $47.9M | $45.0M | $36.9M | $25.8M | $15.7M | $12.8M | $7.6M | $6.2M | $3.8M | $1.6M | $2.6M | $2.2M | $2.1M | $1.5M | $2.7M | $3.0M | $2.3M | $2.1M | $1.9M | $1.7M | $1.6M | |||
| Comprehensive Income Net Of Tax | $24.3M | $35.3M | $25.7M | $4.2M | $12.1M | $12.2M | -$25.5M | -$1.0M | -$2.6M | -$7.4M | -$11.5M | -$10.7M | -$13.0M | -$10.7M | -$7.9M | -$5.1M | -$8.7M | -$8.6M | -$8.2M | -$9.2M | -$6.9M | -$5.1M | -$6.1M | -$4.9M | |||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $100.0K | $9.0K | -$73.0K | -$18.0K | $8.0K | -$68.0K | -$149.0K | $213.0K | $22.0K | $30.0K | $3.0K | $4.0K | |||||||||||||||
| Current Income Tax Expense Benefit | $29.0K | -$41.0K | $196.0K | -$1.5M | $21.0K | $11.0K | $19.0K | $22.0K | $6.0K | $9.0K | $6.0K | $4.0K | $6.0K | $6.0K | $10.0K | $10.0K | $10.0K | $10.0K | $8.0K | $8.0K | $7.0K | ||||||
| Interest Expense | $3.6M | $3.6M | $3.6M | $2.5M | $1.1M | $787.0K | $972.0K | $960.0K | $979.0K | $965.0K | $952.0K | $971.0K | $1.0M | $1.0M | $1.1M | $1.1M | $1.1M | $1.1M | $313.0K | $258.0K | |||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Other Nonoperating Income Expense | $5.0M | $2.4M | $555.0K | -$1.1M | -$784.0K | -$227.0K | -$249.0K | $171.0K | -$454.0K | $499.0K | $371.0K | $217.0K | $56.0K | $247.0K | -$103.0K | $101.0K | -$428.0K | $175.0K | |||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $23.0M | $36.2M | $26.7M | $4.2M | $12.2M | $12.4M | -$26.9M | -$980.0K | -$2.6M | -$7.4M | -$11.5M | -$10.6M | -$13.0M | -$10.7M | -$7.9M | ||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$13.0M | -$10.7M | -$7.9M | -$5.1M | -$8.5M | -$8.8M | -$8.3M | -$9.2M | -$6.9M | -$5.1M | -$6.1M | -$4.9M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $473.1M | $228.6M | $137.2M | $187.4M | $67.9M | $103.9M | $54.6M | -$192.2M | -$168.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $488.9M | $337.2M | $395.3M | $201.7M | $26.1M | $25.1M | $20.6M | $20.7M | $12.4M |
| Inventory Transfer To Property Plant And Equipment | $5.7M | $5.8M | $4.6M | $2.1M | $1.8M | $1.2M | $2.1M | $1.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $151.7M | -$58.2M | $193.6M | $175.6M | $999.0K | $4.5M | -$149.0K | $8.3M | |
| Cash And Cash Equivalents At Carrying Value | $394.8M | $201.2M | $25.6M | $24.6M | $20.1M | $20.2M | |||
| Retained Earnings Accumulated Deficit | -$278.0M | -$468.2M | -$503.7M | -$478.7M | -$442.4M | -$398.2M | -$369.5M | -$335.9M | |
| Restricted Cash Noncurrent | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | |
| Property Plant And Equipment Net | $327.7M | $286.0M | $173.9M | $19.2M | $9.8M | $4.8M | $4.8M | $3.5M | |
| Prepaid Expense And Other Assets Current | $16.3M | $16.3M | $8.0M | $2.9M | $5.5M | $2.3M | $1.5M | $1.8M | |
| Liabilities Current | $89.3M | $59.9M | $54.9M | $23.7M | $23.2M | $11.9M | $16.1M | $12.6M | |
| Liabilities And Stockholders Equity | $1.07B | $804.1M | $706.0M | $277.1M | $134.9M | $152.0M | $105.3M | $42.2M | |
| Liabilities | $595.3M | $575.5M | $568.8M | $89.8M | $67.0M | $48.1M | $50.7M | $47.9M | |
| Inventory Net | $48.9M | $46.6M | $44.2M | $20.6M | $14.9M | $11.9M | $11.2M | $9.3M | |
| Contract With Customer Liability Current | $2.9M | $1.7M | $2.0M | $241.0K | $250.0K | $263.0K | $166.0K | $306.0K | |
| Assets Current | $637.8M | $497.2M | $510.7M | $252.3M | $118.7M | $146.8M | $100.0M | $34.8M | |
| Assets | $1.07B | $804.1M | $706.0M | $277.1M | $134.9M | $152.0M | $105.3M | $42.2M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $124.0K | -$364.0K | -$199.0K | -$225.0K | -$188.0K | -$95.0K | -$2.0K | -$101.0K | |
| Accrued Liabilities And Other Liabilities | $62.7M | $45.2M | $38.2M | $18.6M | $16.3M | $10.4M | $8.3M | $7.2M | |
| Accounts Receivable Net Current | $84.3M | $97.7M | $63.6M | $27.6M | $5.9M | $6.9M | $6.6M | $3.4M | |
| Accounts Payable Current | $10.4M | $10.3M | $12.7M | $3.3M | $6.7M | $1.2M | $7.2M | $4.7M | |
| Non Cash Interest And End Of Term Accretion Expense | $3.1M | $3.1M | $2.1M | $465.0K | $540.0K | $511.0K | $475.0K | $177.0K | |
| Common Stock Value | $750.9M | $697.2M | $641.1M | $666.3M | $510.5M | $502.2M | $424.1M | $1.0K | |
| Other Assets Noncurrent | $239.0K | $208.0K | $62.0K | $6.0K | $6.0K | $6.0K | |||
| Restricted Cash And Cash Equivalents | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | ||||
| Amortization Of Debt Discount Premium | $381.0K | $1.4M | $634.0K | -$205.0K | $9.0K | ||||
| Long Term Debt Noncurrent | $35.2M | $34.7M | $34.1M | $33.7M | |||||
| Operating Lease Right Of Use Asset | $5.2M | $6.5M | $6.5M | $5.1M | $5.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $355.2M | $318.1M | $266.3M | $209.9M | $189.9M | $159.5M | $126.5M | $145.2M | $192.6M | $187.9M | $50.9M | $59.9M | $78.5M | $89.0M | $97.7M | $109.6M | $113.8M | $46.7M | $63.5M | $71.2M | -$199.0M | -$184.7M | -$179.7M | -$173.6M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $466.7M | $401.1M | $310.6M | $330.6M | $363.3M | $350.7M | $427.6M | $583.0M | $196.1M | $205.0M | $30.9M | $18.4M | $23.0M | $25.8M | $27.2M | $21.9M | $51.7M | $25.2M | $20.9M | $47.7M | $12.7M | $29.4M | $34.9M | $10.3M | |
| Inventory Transfer To Property Plant And Equipment | $1.3M | $1.2M | $317.0K | $1.0M | $429.0K | $78.0K | $407.0K | $342.0K | |||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$26.5M | -$44.6M | -$5.6M | -$7.7M | $2.1M | $4.6M | -$8.0M | -$2.1M | |||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $330.1M | $362.8M | $350.2M | $427.1M | $582.2M | $195.4M | $204.5M | $30.4M | $17.9M | $22.5M | $25.3M | $26.7M | $21.4M | $51.2M | $24.7M | $20.4M | $47.2M | $12.2M | |||||||
| Retained Earnings Accumulated Deficit | -$383.3M | -$407.7M | -$442.6M | -$475.1M | -$479.3M | -$491.5M | -$507.7M | -$482.3M | -$481.3M | -$472.0M | -$464.5M | -$453.0M | -$429.8M | -$416.8M | -$406.1M | -$391.9M | -$386.8M | -$378.3M | -$360.3M | -$352.0M | -$342.8M | ||||
| Restricted Cash Noncurrent | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $750.0K | $750.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | ||||
| Property Plant And Equipment Net | $313.0M | $312.3M | $311.2M | $271.7M | $229.0M | $214.4M | $131.0M | $20.0M | $19.2M | $18.5M | $16.2M | $12.0M | $5.1M | $5.0M | $4.7M | $4.7M | $4.4M | $4.7M | $4.7M | $4.4M | $3.8M | ||||
| Prepaid Expense And Other Assets Current | $21.6M | $13.8M | $10.4M | $20.1M | $16.7M | $7.6M | $9.6M | $2.4M | $3.8M | $5.5M | $6.6M | $5.4M | $3.7M | $3.5M | $3.2M | $2.3M | $1.9M | $1.7M | $2.1M | $1.6M | $1.4M | ||||
| Liabilities Current | $79.7M | $56.6M | $55.6M | $60.0M | $54.3M | $50.2M | $49.1M | $32.0M | $28.6M | $20.7M | $22.7M | $20.3M | $15.9M | $15.1M | $11.8M | $13.6M | $13.8M | $15.0M | $14.6M | $15.4M | $16.2M | ||||
| Liabilities And Stockholders Equity | $946.0M | $890.5M | $837.5M | $785.6M | $758.6M | $723.8M | $689.2M | $690.4M | $287.1M | $274.9M | $117.3M | $124.0M | $131.1M | $140.5M | $145.8M | $159.3M | $163.1M | $96.9M | $112.6M | $121.0M | $38.8M | ||||
| Liabilities | $590.8M | $572.4M | $571.2M | $575.7M | $568.7M | $564.4M | $562.8M | $545.1M | $94.5M | $87.0M | $66.4M | $64.1M | $52.6M | $51.5M | $48.1M | $49.8M | $49.4M | $50.2M | $49.1M | $49.9M | $51.3M | ||||
| Inventory Net | $44.5M | $38.9M | $43.4M | $52.2M | $48.7M | $48.5M | $39.4M | $30.5M | $24.0M | $18.6M | $17.5M | $16.7M | $14.9M | $13.0M | $11.8M | $13.0M | $12.6M | $11.4M | $10.5M | $11.2M | $11.3M | ||||
| Contract With Customer Liability Current | $3.3M | $1.6M | $2.1M | $2.2M | $1.4M | $2.1M | $2.6M | $244.0K | $244.0K | $226.0K | $238.0K | $247.0K | $320.0K | $473.0K | $432.0K | $1.3M | $1.0M | $164.0K | $162.0K | $175.0K | $359.0K | ||||
| Assets Current | $613.0M | $558.1M | $505.9M | $492.5M | $509.3M | $488.3M | $536.7M | $662.7M | $261.7M | $250.6M | $95.1M | $105.8M | $125.6M | $135.1M | $140.5M | $154.1M | $158.2M | $91.7M | $107.4M | $116.1M | $30.1M | ||||
| Assets | $946.0M | $890.5M | $837.5M | $785.6M | $758.6M | $723.8M | $689.2M | $690.4M | $287.1M | $274.9M | $117.3M | $124.0M | $131.1M | $140.5M | $145.8M | $159.3M | $163.1M | $96.9M | $112.6M | $121.0M | $38.8M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $101.0K | $98.0K | -$327.0K | -$233.0K | -$237.0K | -$182.0K | -$262.0K | -$220.0K | -$218.0K | -$247.0K | -$306.0K | -$285.0K | -$131.0K | -$134.0K | -$89.0K | -$16.0K | $36.0K | $227.0K | $20.0K | -$58.0K | -$67.0K | ||||
| Accrued Liabilities And Other Liabilities | $56.0M | $42.5M | $40.1M | $42.2M | $37.7M | $36.9M | $31.7M | $22.9M | $22.6M | $16.0M | $15.4M | $15.7M | $12.8M | $12.1M | $9.9M | $11.5M | $8.9M | $9.9M | $9.3M | $8.2M | $10.0M | ||||
| Accounts Receivable Net Current | $80.7M | $104.9M | $142.0M | $90.1M | $81.2M | $81.9M | $60.7M | $47.5M | $38.6M | $22.0M | $13.0M | $11.7M | $4.2M | $6.3M | $7.4M | $6.1M | $4.4M | $6.1M | $6.5M | $7.1M | $5.1M | ||||
| Accounts Payable Current | $12.2M | $9.5M | $10.6M | $13.1M | $13.0M | $9.2M | $12.8M | $7.0M | $4.3M | $3.1M | $5.7M | $2.9M | $2.7M | $2.4M | $1.3M | $778.0K | $3.7M | $4.9M | $4.8M | $6.7M | $5.5M | ||||
| Non Cash Interest And End Of Term Accretion Expense | $787.0K | $772.0K | $106.0K | $137.0K | $130.0K | $123.0K | $115.0K | ||||||||||||||||||
| Common Stock Value | $738.4M | $725.7M | $709.2M | $685.3M | $669.4M | $651.2M | $634.5M | $627.7M | $674.2M | $660.1M | $515.8M | $513.2M | $508.5M | $505.9M | $503.9M | $501.5M | $500.6M | $424.8M | $1.0K | ||||||
| Other Assets Noncurrent | $226.0K | $221.0K | $211.0K | $163.0K | $84.0K | $85.0K | $60.0K | $59.0K | $508.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |||||||
| Restricted Cash And Cash Equivalents | $500.0K | $500.0K | $500.0K | $500.0K | $750.0K | $750.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | |||||||
| Amortization Of Debt Discount Premium | $228.0K | $391.0K | $1.0K | $9.0K | |||||||||||||||||||||
| Long Term Debt Noncurrent | $58.8M | $58.7M | $58.5M | $35.5M | $35.3M | $35.1M | $34.9M | $34.8M | $34.5M | $34.4M | $34.3M | $34.0M | $33.9M | $33.8M | |||||||||||
| Operating Lease Right Of Use Asset | $5.7M | $5.8M | $6.0M | $6.9M | $5.9M | $6.2M | $6.9M | $6.9M | $4.9M | $5.3M | $5.5M | $5.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Adjustments To Common Stock Share Based Compensation Stock Options Requisite Service Period Recognition | $36.9M | $33.2M | $19.8M | $10.3M | $6.9M | $2.4M | ||
| Share Based Compensation | $36.9M | $33.2M | $19.8M | $10.3M | $6.9M | $2.4M | $854.0K | $144.0K |
| Proceeds From Stock Options Exercised | $13.7M | $20.8M | $6.2M | $4.7M | $974.0K | $227.0K | $202.0K | $46.0K |
| Payments To Acquire Property Plant And Equipment | $59.3M | $129.7M | $151.8M | $11.9M | $3.5M | $455.0K | $165.0K | $418.0K |
| Net Cash Provided By Used In Operating Activities | $192.8M | $48.8M | -$13.0M | -$45.8M | -$28.9M | -$30.3M | -$32.3M | -$26.0M |
| Net Cash Provided By Used In Investing Activities | -$59.3M | -$129.3M | -$194.0M | $54.5M | $29.3M | -$41.6M | -$60.5M | $12.3M |
| Net Cash Provided By Used In Financing Activities | $16.9M | $22.9M | $400.4M | $167.9M | $1.4M | $75.5M | $92.7M | $22.1M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $3.8M | $6.3M | $2.1M | -$2.5M | $3.2M | $769.0K | -$250.0K | $1.4M |
| Increase Decrease In Inventories | $7.7M | $8.4M | $28.1M | $8.0M | $4.9M | $1.7M | $4.1M | $2.7M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $17.7M | $7.9M | $14.3M | $3.4M | $4.9M | $1.9M | $2.5M | $2.3M |
| Increase Decrease In Accounts Receivable | -$14.0M | $34.3M | $33.8M | $21.7M | -$840.0K | $218.0K | $3.2M | $2.5M |
| Increase Decrease In Accounts Payable | -$19.0K | -$1.4M | $7.0M | -$3.3M | $5.1M | -$5.8M | $3.4M | $164.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.3M | -$536.0K | $193.0K | -$1.0M | -$797.0K | $803.0K | -$85.0K | -$82.0K |
| Depreciation Depletion And Amortization | $27.2M | $19.8M | $8.2M | $3.5M | $1.8M | $1.6M | $1.2M | $769.0K |
| Proceeds From Stock Plans | $3.2M | $2.1M | $955.0K | $509.0K | $419.0K | $357.0K | ||
| Increase Decrease In Contract With Customer Liability | $1.1M | -$203.0K | $83.0K | $7.0K | $60.0K | -$136.0K | $67.0K | |
| Proceeds From Sale And Maturity Of Marketable Securities | $76.9M | $104.8M | $80.7M | $22.0M | $12.7M | |||
| Payments To Acquire Marketable Securities | $10.5M | $72.0M | $121.8M | $82.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Common Stock Share Based Compensation Stock Options Requisite Service Period Recognition | $9.1M | $9.4M | $9.0M | $7.9M | $7.6M | $6.9M | $5.2M | $5.0M | $3.9M | $2.7M | $2.3M | $2.3M | $2.0M | $1.8M | $1.1M | $700.0K | $631.0K | $385.0K | ||
| Share Based Compensation | $9.0M | $6.9M | $3.9M | $2.3M | $1.1M | $385.0K | $57.0K | $27.0K | ||||||||||||
| Proceeds From Stock Options Exercised | $1.7M | $2.5M | $3.6M | $202.0K | $372.0K | $75.0K | $8.0K | $12.0K | ||||||||||||
| Payments To Acquire Property Plant And Equipment | $27.0M | $44.2M | $927.0K | $2.0M | $20.0K | $277.0K | $3.0K | $40.0K | ||||||||||||
| Net Cash Provided By Used In Operating Activities | -$2.9M | -$3.4M | -$8.7M | -$18.4M | -$7.3M | -$8.2M | -$7.3M | -$6.3M | ||||||||||||
| Net Cash Provided By Used In Investing Activities | -$27.0M | -$44.2M | -$927.0K | $10.5M | $9.3M | $12.7M | -$3.0K | $5.0M | ||||||||||||
| Net Cash Provided By Used In Financing Activities | $3.0M | $3.2M | $4.0M | $405.0K | $583.0K | $152.0K | -$697.0K | -$880.0K | ||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.9M | $1.6M | $884.0K | -$88.0K | $908.0K | $120.0K | -$417.0K | $143.0K | ||||||||||||
| Increase Decrease In Inventories | -$2.0M | $5.6M | $3.6M | $2.9M | $381.0K | $241.0K | $2.5M | $1.2M | ||||||||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$4.6M | -$49.0K | $3.5M | -$4.0K | -$180.0K | $1.8M | $2.4M | $1.7M | ||||||||||||
| Increase Decrease In Accounts Receivable | $44.1M | $18.4M | $11.0M | $5.8M | $583.0K | -$422.0K | $1.7M | $1.0M | ||||||||||||
| Increase Decrease In Accounts Payable | $781.0K | -$2.0M | $1.0M | -$4.0M | -$82.0K | -$2.4M | $758.0K | -$843.0K | ||||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $358.0K | -$173.0K | $73.0K | -$196.0K | -$379.0K | -$45.0K | -$60.0K | $114.0K | ||||||||||||
| Depreciation Depletion And Amortization | $6.1M | $4.3M | $1.3M | $507.0K | $445.0K | $371.0K | $245.0K | $166.0K | ||||||||||||
| Proceeds From Stock Plans | $1.3M | $638.0K | $384.0K | $203.0K | $211.0K | $197.0K | ||||||||||||||
| Increase Decrease In Contract With Customer Liability | $330.0K | $108.0K | $182.0K | $57.0K | -$4.0K | |||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $14.5M | $21.0M | $17.2M | $5.0M | ||||||||||||||||
| Payments To Acquire Marketable Securities | $2.0M | $11.7M | $4.2M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $4.87 | $1.01 | -$0.77 | -$1.23 | -$1.60 | -$1.16 | -$2.36 | -$17.48 |
| Weighted Average Number Of Shares Outstanding Basic | 34.0M | 33.2M | 32.5M | 29.6M | 27.6M | 24.7M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 40.5M | 35.2M | 32.5M | 29.6M | 27.6M | 24.7M | ||
| Earnings Per Share Basic | $5.60 | $1.07 | $-0.77 | $-1.23 | $-1.60 | $-1.16 | ||
| Preferred Stock Shares Authorized | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Shares Outstanding | 34.3M | 33.6M | 32.7M | 32.1M | 27.8M | 27.2M | ||
| Common Stock Shares Issued | 34.3M | 33.6M | 32.7M | 32.1M | 27.8M | 27.2M | ||
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.66 | $0.92 | $0.70 | $0.12 | $0.35 | $0.35 | -$0.78 | -$0.03 | -$0.08 | -$0.25 | -$0.41 | -$0.38 | -$0.47 | -$0.39 | -$0.29 | -$0.23 | -$0.19 | -$0.36 | -$0.42 | -$0.43 | -$0.39 | -$0.70 | -$4.86 | -$5.48 | -$3.73 | -$4.57 | -$3.61 |
| Weighted Average Number Of Shares Outstanding Basic | 34.1M | 33.9M | 33.7M | 33.4M | 33.1M | 32.8M | 32.6M | 32.5M | 32.3M | 30.2M | 28.0M | 28.0M | 27.7M | 27.6M | 27.4M | 27.2M | 23.3M | 21.2M | |||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 40.7M | 40.6M | 39.9M | 35.7M | 35.3M | 34.7M | 32.6M | 32.5M | 32.3M | 30.2M | 28.0M | 28.0M | 27.7M | 27.6M | 27.4M | 27.2M | 23.3M | 21.2M | |||||||||
| Earnings Per Share Basic | $0.71 | $1.03 | $0.76 | $0.13 | $0.37 | $0.37 | $-0.78 | $-0.03 | $-0.08 | $-0.25 | $-0.41 | $-0.38 | $-0.47 | $-0.39 | $-0.29 | $-0.19 | $-0.36 | $-0.42 | |||||||||
| Preferred Stock Shares Authorized | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | ||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Common Stock Shares Outstanding | 34.1M | 34.0M | 33.8M | 33.6M | 33.3M | 32.9M | 32.6M | 32.6M | 32.5M | 31.9M | 28.0M | 28.0M | 27.8M | 27.6M | 27.5M | 27.2M | 27.1M | 21.3M | 21.2M | 21.1M | 1.4M | 1.4M | |||||
| Common Stock Shares Issued | 34.1M | 34.0M | 33.8M | 33.6M | 33.3M | 32.9M | 32.6M | 32.6M | 32.5M | 31.9M | 28.0M | 28.0M | 27.8M | 27.6M | 27.5M | 27.2M | 27.1M | 21.3M | 21.2M | 21.1M | 1.4M | 1.4M | |||||
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 60.0M | 60.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $13.7M | $20.8M | $6.2M | $4.7M | $974.0K | $227.0K | $202.0K | $46.0K |
| Stock Issued During Period Value Employee Stock Purchase Plan | $3.2M | $2.1M | $955.0K | $509.0K | $419.0K | $357.0K | ||
| Foreign Currency Transaction Gain Loss Unrealized | $1.6M | -$665.0K | $342.0K | -$1.1M | -$928.0K | $1.1M | -$200.0K | -$150.0K |
| Capital Expenditures Incurred But Not Yet Paid | $1.8M | $2.1M | $2.5M | $62.0K | $1.2M | $169.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $1.8M | $7.1M | $1.7M | $6.4M | $10.6M | $2.5M | $952.0K | $705.0K | $3.6M | $1.4M | $237.0K | $202.0K | $344.0K | $213.0K | $372.0K | $27.0K | $92.0K | $75.0K | $94.0K | $6.0K | $8.0K | $24.0K | $9.0K | $12.0K |
| Stock Issued During Period Value Employee Stock Purchase Plan | $2.0M | $1.3M | $1.4M | $638.0K | $571.0K | $384.0K | $306.0K | $203.0K | $208.0K | $211.0K | $160.0K | $197.0K | ||||||||||||
| Foreign Currency Transaction Gain Loss Unrealized | $573.0K | -$199.0K | $137.0K | -$214.0K | -$484.0K | -$78.0K | -$160.0K | $143.0K | ||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $1.1M | $1.2M | $30.0K | $939.0K | $7.0K | $112.0K | $129.0K | $4.0K |
Most recent annual filing with the SEC: February 24, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.